Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (12): 1276-1279.doi: 10.3969/j.issn.1000-6621.2020.12.005
Special Issue: 标准、共识、指南
• Special Articles • Previous Articles Next Articles
LIANG Jian-qin, WU Xue-qiong()
Received:
2020-10-11
Online:
2020-12-10
Published:
2020-12-24
Contact:
WU Xue-qiong
E-mail:xueqiongwu@139.com
LIANG Jian-qin, WU Xue-qiong. Interpretation of Expert consensus on detection and clinical application of peripheral blood lymphocyte subsets in patients with tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1276-1279. doi: 10.3969/j.issn.1000-6621.2020.12.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.12.005
[1] | United States Department of Health and Human Services Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers. Atlanta: United States Centers for Disease Control and Prevention, 2020.[2020-10-16]. https://www.cdc.gov/tb/publications/ltbi/pdf/LTBIbooklet508.pdf. |
[2] | 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础专业和临床专业学术部. 结核病患者外周血淋巴细胞亚群检测及临床应用专家共识. 中国防痨杂志, 2020,42(10):1009-1016. doi: 10.3969/j.issn.1000-6621.2020.10.001. |
[3] |
Guidelines for the performance of CD4+T-cell determinations in persons with human immunodeficiency virus infection. MMWR Recomm Rep, 1992,41(RR-8):1-17.
URL pmid: 1350319 |
[4] | National Committee for Clinical Laboratory Standard. Clinical applications of flow cytometry: immunophenotyping of lymphocytes. Approved guideline. NCCLS Document H42-A. New York: National Committee for Clinical Laboratory Stan-dards, 1998. |
[5] | 中华人民共和国卫生部. WS/T 360—2011 流式细胞术检测外周血淋巴细胞亚群指南. 2011-12-14. |
[6] |
Lee BW, Yap HK, Chew FT, et al. Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry, 1996,26(1):8-15. doi: 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E.
doi: 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E URL pmid: 8809475 |
[7] | 朱立华, 王建中. 中国人血液淋巴细胞免疫表型参考值调查. 中华医学检验杂志, 1998,21(4):223-226. doi: 10.3760/j:issn:1009-9158.1998.04.010. |
[8] | 张琰, 温浩, 张朝霞, 等. 新疆地区维吾尔族和汉族血液淋巴细胞免疫表型参考值范围的调查. 中国实验血液学杂志, 2006,14(1):133-136. doi: 10.3969/j.issn.1009-2137.2006.01.030. |
[9] |
Chng WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol, 2004,11(1):168-173. doi: 10.1128/cdli.11.1.168-173.2004.
doi: 10.1128/cdli.11.1.168-173.2004 URL pmid: 14715565 |
[10] | 张诗诗, 王薇, 何法霖, 等. 全国流式细胞术淋巴细胞亚群项目健康成人参考区间现状分析. 中华检验医学杂志, 2016,39(5):356-360. doi: 10.3760/cma.j.issn.1009-9158.2016.05.007. |
[11] | 赵宏, 焦顺昌, 张国庆, 等. 不同年龄、性别的健康成年人21项淋巴细胞亚群分析. 标记免疫分析与临床, 2011,18(2):99-102. doi: 10.3969/j.issn.1006-1703.2011.02.013. |
[12] | 许遵鹏, 李蓓, 廖灿, 等. 广州市健康儿童和成人淋巴细胞亚群数量的对比分析. 中国优生与遗传杂志, 2012,20(2):126-128,125. |
[13] | 杨雪, 焦艳梅, 吴昊. CD4+T淋巴细胞亚群研究进展. 北京医学, 2011,33(12):1001-1003. |
[14] | 李高波, 张涛, 刘晓辉. T淋巴细胞亚群对初治活动性肺结核病人痰菌与PPD结果的影响. 现代预防医学, 2008,35(3):569-570, 572. doi: 10.3969/j.issn.1003-8507.2008.03.082. |
[15] | 喻容, 周添荣, 石国民, 等. 耐多药结核病患者细胞免疫功能的初步研究. 实用预防医学, 2016,23(10):1199-1202. doi: 10.3969/j.issn.1006-3110.2016.10.015. |
[16] |
Morais-Papini TF, Coelho-Dos-Reis JGA, Wendling APB, et al. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection. Immunobiology, 2017,222(11):1014-1024. doi: 10.1016/j.imbio.2017.05.016.
doi: 10.1016/j.imbio.2017.05.016 URL pmid: 28619539 |
[17] | 何畏, 陈晴, 黄涛, 等. 肺结核及肺外结核患者外周血T淋巴细胞亚群的变化及其临床意义. 中国防痨杂志, 2019,41(10):1090-1095. doi: 10.3969/j.issn.1000-6621.2019.10.005. |
[18] | 沈洁, 吴妹英, 李苏梅. 初治和复治肺结核患者外周血淋巴细胞亚群的变化及其临床意义. 临床肺科杂志, 2019,24(2):208-212. doi: 10.3969/j.issn.1009-6663.2019.02.004. |
[19] |
Wu YE, Zhang SW, Peng WG, et al. Changes in lymphocyte subsets in the peripheral blood of patients with active pulmonary tuberculosis. J Int Med Res, 2009,37(6):1742-1749. doi: 10.1177/147323000903700610.
doi: 10.1177/147323000903700610 URL pmid: 20146872 |
[20] |
Zhang Q, Xiao HP, Cui HY, et al. Significant increase in na-tural-killer T cells in patients with tuberculosis complicated by type 2 diabetes mellitus. J Int Med Res, 2011,39(1):105-111. doi: 10.1177/147323001103900113.
doi: 10.1177/147323001103900113 URL pmid: 21672313 |
[21] |
Sada-Ovalle I, Chiba A, Gonzales A, et al. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog, 2008,4(12):e1000239. doi: 10.1371/journal.ppat.1000239.
doi: 10.1371/journal.ppat.1000239 URL pmid: 19079582 |
[22] |
Sridhar CB, Kini U, Subhash K. Comparative cytological study of lymph node tuberculosis in HIV-infected individuals and in patients with diabetes in a developing country. Diagn Cytopathol, 2002,26(2):75-80. doi: 10.1002/dc.10059.
doi: 10.1002/dc.10059 URL pmid: 11813322 |
[23] | 石文卉, 陈维, 荆玮, 等. 肺结核患者淋巴细胞亚群检测结果与临床特征的相关性探讨. 中国防痨杂志, 2017,39(2):140-144. doi: 10.3969/j.issn.1000-6621.2017.02.007. |
[24] |
Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune di-seases . Nat Rev Immunol, 2010,10(12):849-859. doi: 10.1038/nri2889.
doi: 10.1038/nri2889 URL pmid: 21107346 |
[25] |
Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science, 2011,331(6013):44-49. doi: 10.1126/science.1198687.
doi: 10.1126/science.1198687 URL pmid: 21212348 |
[26] | 陶思雨, 姜石松, 申元英, 等. 机体抗结核分枝杆菌感染的免疫机制研究进展. 中国病原生物学杂志, 2020,15(2):233-237. doi: 10.13350/j.cjpb.200223. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||